EMILIO
BOUZA SANTIAGO
Researcher to 2020
MARÍA PILAR
ESCRIBANO SUBÍAS
Profesora asociada de Ciencias de la Salud
Publications by the researcher in collaboration with MARÍA PILAR ESCRIBANO SUBÍAS (28)
2023
2022
-
Different performance of three point-of-care SARS-CoV-2 antigen detection devices in symptomatic patients and close asymptomatic contacts: a real-life study
Clinical Microbiology and Infection, Vol. 28, Núm. 6, pp. 865-870
-
High incidence of COVID-19 at nursing homes in Madrid, Spain, despite preventive measures
Revista Espanola de Quimioterapia, Vol. 35, Núm. 3, pp. 288-292
-
Incidence of Candidemia Is Higher in COVID-19 versus Non-COVID-19 Patients, but Not Driven by Intrahospital Transmission
Journal of Fungi, Vol. 8, Núm. 3
-
Nosocomial Transmission of SARS-CoV-2 Involving Vaccinated Health Care Workers
Microbiology Spectrum, Vol. 10, Núm. 1
2021
-
Inference of active viral replication in cases with sustained positive reverse transcription-PCR results for SARS-CoV-2
Journal of Clinical Microbiology, Vol. 59, Núm. 2
-
Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity
Mycoses, Vol. 64, Núm. 2, pp. 132-143
2020
-
Corrigendum to ‘Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect’ [Clinical Microbiology and Infection, Volume 24, (Issue 12) (December 2018) Pages 1343.e1-1343.e4](S1198743X18305214)(10.1016/j.cmi.2018.07.006)
Clinical Microbiology and Infection
-
Corrigendum to “Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect” [Clin Microbiol Infect 24 (12) (December 2018) 1343.e1-1343.e4](10.1016/j.cmi.2018.07.006)
Clinical Microbiology and Infection
-
Erratum: Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates (PLOS ONE (2017) 12:6 (e0179136) DOI: 10.1371/Journal.pone.0179136)
PLoS ONE
-
Erratum: Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect (Clinical Microbiology and Infection (2018) 24(12) (1343.e1–1343.e4), (S1198743X18305214), (10.1016/j.cmi.2018.07.006))
Clinical Microbiology and Infection
-
Invasive Scedosporium and Lomentosora infections in the era of antifungal prophylaxis: A 20-year experience from a single centre in Spain
Mycoses, Vol. 63, Núm. 11, pp. 1195-1202
-
Outbreak of COVID-19 in a nursing home in Madrid
Journal of Infection
-
Therapeutic Drug Monitoring of Antifungal Drugs: Another Tool to Improve Patient Outcome?
Infectious Diseases and Therapy, Vol. 9, Núm. 1, pp. 137-149
2019
-
Detection of Echinocandin-Resistant Candida glabrata in Blood Cultures Spiked with Different Percentages of FKS2 Mutants
Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 3
-
Erratum: Growth kinetics in Candida spp.: Differences between species and potential impact on antifungal susceptibility testing as described by the EUCAST (Medical Mycology (2018) DOI: 10.1093/mmy/myy097)
Medical Mycology
-
Fatal disseminated infection by Gymnascella hyalinospora in a heart transplant recipient
Transplant Infectious Disease, Vol. 21, Núm. 5
-
Fluconazole resistance is not a predictor of poor outcome in patients with cryptococcosis
Mycoses, Vol. 62, Núm. 5, pp. 441-449
-
Increased species-assignment of filamentous fungi using MALDI-TOF MS coupled with a simplified sample processing and an in-house library
Medical Mycology, Vol. 57, Núm. 1, pp. 63-70
-
Infectious endocarditis caused by Candida glabrata: Evidence of in vivo development of echinocandin resistance
Revista Espanola de Quimioterapia